Journal Report

BJU International

Download PDF
Journal Information
Journal Title
BJU International
Publisher
John Wiley and Sons Inc
ISSN
1464-4096
E-ISSN
1464-410X
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
The impact of programmed death ligand 1 expression on prognosis in penile cancer: a systematic review and meta‐analysis
Diarmuid D. Sugrue, Orla Cullivan, Eoghan Cunnane et al.
2026-11-3
DOI: 10.1111/bju.70526
Beyond the label ‘high‐grade’: histological heterogeneity as a prognostic marker in Ta non‐muscle‐invasive bladder cancer
Francis Simard, Marie‐Maxime Lacombe, David Simonyan et al.
2026-11-2
DOI: 10.1111/bju.70522
Automated urine analysis of atypical urothelial cells for urothelial carcinoma: a prospective study
Maximilian Reimann, Thorsten Schlomm, Nathalie Winkler et al.
2026-11-2
DOI: 10.1111/bju.70523
Patient‐reported sensory outcomes in gender‐affirming phalloplasty: a single‐centre experience
Danielle J. Eble, Elliot Burghardt, Jens U. Berli et al.
2026-11-2
DOI: 10.1111/bju.70521
Urethroplasty for bulbomembranous strictures after benign prostatic hyperplasia surgery: systematic review and meta‐analysis
Pietro Scilipoti, Federico Zorzi, Andrea Folcia et al.
2026-10-31
DOI: 10.1111/bju.70524
Evaluation of <scp>StoneSense</scp> ™ automatic target recognition in thulium fibre laser lithotripsy: a multi‐model <i>in vitro</i> study
Maxton E. Thoman, Pedro Z. Padovani, Bristol B. Whiles et al.
2026-10-29
DOI: 10.1111/bju.70512
Opposing roles of acid phosphatase 1 (ACP1) and ACP3 in prostate cancer progression
Alessandra V. de S. Faria, Carmen V. Ferreira‐Halder, Maikel P. Peppelenbosch et al.
2026-10-28
DOI: 10.1111/bju.70515
Grade Group 1 prostate cancer: indolent but not innocent
Francesca Khani, Michelle S. Hirsch, Massimo Loda
2026-10-28
DOI: 10.1111/bju.70520
Prostate‐specific membrane antigen defined oligoprogressive castration‐resistant prostate cancer: is metastasis‐directed therapy ready for prime time?
Fernando Munoz, Benedikt Engels
2026-10-27
DOI: 10.1111/bju.70493
Reply to: Prostate‐specific membrane antigen‐ <scp>PET</scp> ‐defined oligoprogressive castration‐resistant prostate cancer: is metastasis‐directed therapy ready for prime time?
Tobias Hölscher, Fabian Lohaus
2026-10-26
DOI: 10.1111/bju.70494
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 3, 2026 19:59